Dissemination of KPC-2-producing carbapenem-resistant Klebsiella pneumoniae ST656 in Eastern China

Carbapenem-resistant Klebsiella pneumoniae (CRKP), particularly strains producing Klebsiella pneumoniae carbapenemase (KPC), pose a severe global health challenge due to limited therapeutic options and high mortality. While ST11 is the predominant KPC-producing lineage in China, the clinical and epidemiological significance of ST656 remains largely unexplored. We conducted a genomic and epidemiological investigation of twenty-five KPC-2-producing K. pneumoniae ST656 isolates collected from patients with severe pulmonary comorbidities in a tertiary hospital in Eastern China between July 2020 and October 2021. Antimicrobial susceptibility testing, whole-genome sequencing (WGS), phylogenetic analysis, plasmid profiling and conjugation assays were performed to determine resistance mechanisms, clonal relationships and plasmid transferability. Clinical information showed all 25 isolates originated from distinct patients in a tertiary hospital in Eastern China, predominantly older male post-lung transplantation cases with severe pulmonary disease, from intensive care units and thoracic surgery wards. All isolates displayed highly similar multidrug-resistant profiles, being resistant to most β-lactams, levofloxacin and trimethoprim-sulfamethoxazole, with limited susceptibility to amikacin and tigecycline. Genomic characterization of representative strain CRE132 showed that blaKPC−2 was located on a conjugative IncFII plasmid, and that this plasmid could transfer carbapenem resistance to Escherichia coli in conjugation assays. ST656 isolates in our study exhibited modest increase in virulence-associated traits, growth rates and certain adaptability compared with ST11 isolates. This study represents the first genomic and epidemiological investigation demonstrating nosocomial clonal dissemination of KPC-2–producing K. pneumoniae ST656 in China. These findings highlight the importance of continued genomic surveillance and improved understanding of this emerging lineage.

Authors

Institutions

Publication Details

Journal
BMC Microbiology
Published
2025-12-18
DOI
https://doi.org/10.1186/s12866-025-04620-1
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dissemination of KPC-2-producing carbapenem-resistant Klebsiella pneumoniae ST656 in Eastern China

Jianbo Lv, Haojin Gao, Xinru Yuan, Can Yang et al.
BMC Microbiology
Antibiotic Resistance in Bacteria
article

Dissemination of KPC-2-producing carbapenem-resistant Klebsiella pneumoniae ST656 in Eastern China

Jianbo Lv, Haojin Gao, Xinru Yuan, Can Yang, Shen Li, Fangyou Yu, Junhong Shi, Weihua Han, Jinjin Yang, Juanjuan Fu, Zhixuan Chen, Yü Huang, Bingjie Wang
article en

Abstract

Carbapenem-resistant Klebsiella pneumoniae (CRKP), particularly strains producing Klebsiella pneumoniae carbapenemase (KPC), pose a severe global health challenge due to limited therapeutic options and high mortality. While ST11 is the predominant KPC-producing lineage in China, the clinical and epidemiological significance of ST656 remains largely unexplored. We conducted a genomic and epidemiological investigation of twenty-five KPC-2-producing K. pneumoniae ST656 isolates collected from patients with severe pulmonary comorbidities in a tertiary hospital in Eastern China between July 2020 and October 2021. Antimicrobial susceptibility testing, whole-genome sequencing (WGS), phylogenetic analysis, plasmid profiling and conjugation assays were performed to determine resistance mechanisms, clonal relationships and plasmid transferability. Clinical information showed all 25 isolates originated from distinct patients in a tertiary hospital in Eastern China, predominantly older male post-lung transplantation cases with severe pulmonary disease, from intensive care units and thoracic surgery wards. All isolates displayed highly similar multidrug-resistant profiles, being resistant to most β-lactams, levofloxacin and trimethoprim-sulfamethoxazole, with limited susceptibility to amikacin and tigecycline. Genomic characterization of representative strain CRE132 showed that blaKPC−2 was located on a conjugative IncFII plasmid, and that this plasmid could transfer carbapenem resistance to Escherichia coli in conjugation assays. ST656 isolates in our study exhibited modest increase in virulence-associated traits, growth rates and certain adaptability compared with ST11 isolates. This study represents the first genomic and epidemiological investigation demonstrating nosocomial clonal dissemination of KPC-2–producing K. pneumoniae ST656 in China. These findings highlight the importance of continued genomic surveillance and improved understanding of this emerging lineage.

BMC MicrobiologyVol. 26(1)
Tongji University (CN), Shanghai Pulmonary Hospital (CN)
National Natural Science Foundation of China, Shanghai Pulmonary Hospital
Openalex Percentile: Top 64%
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.